© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, BioMarin Pharmaceutical Inc. (BMRN) shows an Average True Range (ATR) of 2.24 and an Enterprise Value of 358.27B. Its average trading volume over the past 3 months is 2.47M, indicating liquidity. These fundamental metrics provide insight into BMRN's underlying financial health and market activity.
| ATR | 2.24 |
| Enterprise Value | 358.27B |
| Avg Vol (3 Months) | 2.47M |
| Avg Vol (10 Days) | 1.91M |
BioMarin Pharmaceutical Inc. (BMRN) technical indicators as of March 10, 2026: the SMA 20 is 2.11%, SMA 50 at 4.67%, and SMA 200 at 8.02%. The RSI 14 value is 56.47, suggesting its current momentum. These technical analysis signals help assess BMRN's price trends and potential future movements.
| SMA 20 | 2.11% |
| SMA 50 | 4.67% |
| SMA 200 | 8.02% |
| RSI 14 | 56.47 |
BioMarin Pharmaceutical Inc. (BMRN) stock performance overview as of March 10, 2026: The 52-week high is $73.18 (currently -16.87% below), and the 52-week low is $50.76 (currently 20.39% above). Over the past year, BMRN's performance is -8.07%, compared to the S&P 500's 17.64% change.
| 52-Week High | 73.18 |
| 52-Week High Chg | -16.87% |
| 52-Week Low | 50.76 |
| 52-Week Low Chg | +20.39% |
| S&P 500 52-Week Chg | 17.64% |
According to market data, BioMarin Pharmaceutical Inc. (BMRN) stock's recent performance metrics show that over the last month, BMRN is 8.71%, with a Year-to-Date (YTD) performance of -5.25%. Over the past year, the stock has seen a -8.07% change. These figures summarize BMRN's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 63.22 | 66.28 | 66.28 | 66.28 | 73.18 | 66.28 |
| Low | 58.5 | 56.87 | 50.9 | 50.76 | 50.76 | 54.07 |
| Performance | -2.43% | +8.71% | +5.67% | -0.44% | -8.07% | -5.25% |
According to current financial data, BMRN stock's P/E (TTM) ratio is 32.96, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for BMRN, including P/S (3.58), P/B (1.89), and P/FCF (15.91), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | BMRN | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | 32.96 | -1.23 | -5.16 | 32.59 |
| P/S (TTM) | 3.58 | 3.71 | 464.92 | 5.98 |
| P/B (TTM) | 1.89 | 0 | 4.92 | 4.7 |
| P/FCF (TTM) | 15.91 | -63.72 | -244.73 | 32.7 |